Cargando…
Microglial MT1 activation inhibits LPS‐induced neuroinflammation via regulation of metabolic reprogramming
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. Although its pathogenesis remains unclear, a number of studies indicate that microglia‐mediated neuroinflammation makes a great contribution to the pathogenesis of PD. Melatonin receptor 1 (MT1) is widely expressed in gli...
Autores principales: | Gu, Chao, Wang, Fen, Zhang, Yu‐Ting, Wei, Shi‐Zhuang, Liu, Jun‐Yi, Sun, Hong‐Yang, Wang, Guang‐Hui, Liu, Chun‐Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208780/ https://www.ncbi.nlm.nih.gov/pubmed/33964119 http://dx.doi.org/10.1111/acel.13375 |
Ejemplares similares
-
The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation
por: Fan, Kai, et al.
Publicado: (2015) -
Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo
por: Guan, Shuyuan, et al.
Publicado: (2023) -
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
por: Malek, Natalia, et al.
Publicado: (2015) -
Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation
por: Pan, Yinbing, et al.
Publicado: (2016) -
Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson’s Disease Mice
por: Yan, Aijuan, et al.
Publicado: (2019)